“Recent Temperature Plateau” May Undermine Case for Global Warming

GlobalWarmingPlateauGraph2009-09-27.jpgSource of graph: online version of the NYT article quoted and cited below.

(p. A10) The world leaders who met at the United Nations to discuss climate change on Tuesday are faced with an intricate challenge: building momentum for an international climate treaty at a time when global temperatures have been relatively stable for a decade and may even drop in the next few years.

The plateau in temperatures has been seized upon by skeptics as evidence that the threat of global warming is overblown. And some climate experts worry that it could hamper treaty negotiations and slow the progress of legislation to curb carbon dioxide emissions in the United States.
. . .

Underscoring just how little clarity there is on short-term temperature fluctuations, researchers from Britain’s climate change office, in a paper published in August, projected “an end to this period of relative stability,” with half the years between now and 2015 exceeding the record-setting global temperatures of 1998.
Whatever the next decade may hold, critics of global warming have lost no time in using the current temperature plateau to build their case.
“I think it supports the arguments of those who’ve said, ‘What’s the rush for policy on this issue?’ ” said Patrick J. Michaels, a climatologist affiliated with George Mason University and the Cato Institute, a group opposing most regulatory solutions to environmental problems.
. . .

A clearer view of whether the recent temperature plateau undermines arguments for dangerous climate change in the long run should come in a few years, as the predictions made by the British climate researchers are tested. Their paper appeared in a supplement to an August issue of The Bulletin of the American Meteorological Society.
While the authors concluded that there was a 1 in 8 chance of having a decade-long pause in warming like the current plateau, even with rising concentrations of greenhouse gases, the odds of a 15-year pause, they wrote, are only 5 in 100. As a result, the next few years of observations could tip the balance toward further concern or greater optimism.
Meanwhile, social scientists who study the way people understand and respond to environmental problems say it is not surprising that the current temperature stability has created confusion and apathy.

For the full story, see:
ANDREW C. REVKIN. “Plateau in Temperatures Adds Difficulty to Task of Reaching a Solution.” The New York Times (Weds., Sept. 23, 2009): A10.
(Note: the online version lists a date of September 21 and has the title as “Momentum on Climate Pact Is Elusive”, but the body of the article seems to be the same as the print version.)
(Note: ellipses added.)

Scientists Believe Life Emerged from a Process of “Creative Destruction” and Global Warming

CosmicCrashSite2009-09-07.jpgSource of graphic: online version of the WSJ article quoted and cited below.

(p. A9) In a paradox of creation, new evidence suggests that devastating avalanches of cosmic debris may have fostered life on Earth, not annihilated it. If so, life on our planet may be older than scientists previously thought — and more persistent.

Astronomers world-wide have been transfixed by a roiling gash the size of Earth in the atmosphere of Jupiter, caused by an errant comet or asteroid that smashed into the gas giant last month. The lingering turbulence is an echo of a cataclysmic bombardment that shaped the origin of life here 3.9 billion years ago, when millions of asteroids, comets and meteors pummeled our planet.
. . .
But in their super-heated plunge through the atmosphere, these asteroids and meteors may have helped create conditions ideal for emerging life. “Everyone focuses on the meteor that hits the ground,” says geochemist Richard Court at London’s Imperial College. “No one thinks about the products of its journey that get pumped into the atmosphere.”
As they vented, they collectively could have imported billions of tons of life-sustaining water into the air every year, Dr. Court and his colleague Mark Sephton recently determined. They calculated that these showers of volatile rocks delivered 10 times the daily outflow of the Mississippi River every year for 20 million years. By analyzing the fumes emitted under such extreme heat, they discovered these rocks also could have injected billions of tons of carbon dioxide into the air every year.
Combined with so much water vapor, the carbon dioxide could have induced a global greenhouse effect. That could have kept any life emerging on Earth safely in a planetary incubator at a time when the planet might easily have frozen because the Sun radiated 25% less energy than today. “The amount of CO2 that was produced is about the same we produce today through fossil fuel use and we know that is a climate-changing volume,” says Dr. Court.
. . .
“It is literally a revolution in our ideas about how our solar system evolved,” says asteroid expert William Bottke at the Southwest Research Institute. “It could be that our form of life today — every living thing that we see today — is due to this bombardment that happened 3.9 billion years ago.”

For the full commentary, see:
ROBERT LEE HOTZ. “SCIENCE JOURNAL; Some Creative Destruction on a Cosmic Scale; Scientists Say Asteroid Blasts, Once Thought Apocalyptic, Fostered Life on Earth by Carrying Water and Protective Greenhouse Gas.” The Wall Street Journal (Fri., AUGUST 14, 2009): A9.
(Note: ellipses added.)

Global Warming Allows Humans to “Skip” Next Ice Age

SundayLakeAlaska2009-09-06.jpg “Researchers use a floating platform to take sediment cores from Sunday Lake in southwestern Alaska.” Source of photo and caption: online version of the NYT article quoted and cited below.

(p. A17) The human-driven buildup of heat-trapping greenhouse gases in the atmosphere appears to have ended a slide, many millenniums in the making, toward cooler summer temperatures in the Arctic, the authors of a new study report.

Scientists familiar with the work, to be published Friday in the journal Science, said it provided fresh evidence that human activity is not only warming the globe, particularly the Arctic, but could also even fend off what had been presumed to be an inevitable descent into a new ice age over the next few dozen millenniums.
. . .
In the very long term, the ability to artificially warm the climate, particularly the Arctic, could be seen as a boon as the planet’s shifting orientation to the Sun enters a phase that could initiate the next ice age.
As a result of such periodic shifts, 17 ice ages are thought to have come and gone in two million years. The last ice age ended 11,000 years ago and the next one, according to recent research, could be 20,000 or 30,000 years off discounting any influence by humans. The last ice age buried much of the Northern Hemisphere under a mile or more of ice.
With humans’ clear and growing ability to alter the climate, Dr. Overpeck said, “we could easily skip the next opportunity altogether.”

For the full story, see:

ANDREW C. REVKIN. “Global Warming Is Delaying Ice Age, Study Finds.” The New York Times (Fri., September 4, 2009): A17.

(Note: the online version of the article has the title “Global Warming Could Forestall Ice Age.”)
(Note: ellipsis added.)

The reference to the full scientific presentation of the research is:
Kaufman, Darrell S., David P. Schneider, Nicholas P. McKay, Caspar M. Ammann, Raymond S. Bradley, Keith R. Briffa, Gifford H. Miller, Bette L. Otto-Bliesner, Jonathan T. Overpeck, Bo M. Vinther, and Members Arctic Lakes 2k Project. “Recent Warming Reverses Long-Term Arctic Cooling.” Science 325, no. 5945 (2009): 1236-39.

“The Evidence of His Eyes Overturned 2,000 Years of Accepted Wisdom”

GalileoShowsVenetianSenators.jpg“. . ., the Italian astronomer shows the satellites of Jupiter to Venetian senators in this 1882 illustration.” Source of illustration and caption: online version of the WSJ article quoted and cited below.

(p. A9) A mathematician and experimental physicist, Galileo, however, immediately recognized that what he could see of Venus, Jupiter and the moon through his telescope offered crucial evidence that the sun, not Earth, was the center of our solar system. The evidence of his eyes overturned 2,000 years of accepted wisdom about cosmology in which philosophers had conceived the night sky as a system of crystalline spheres.

Moreover, Galileo quickly shared his observations with scientists throughout Europe by openly publishing his data.
“He wrought a change so fundamental for science and for humanity,” says Munich astronomer Pedro Russo, who is global coordinator of the International Year of Astronomy. “For the first time, we realized we were not the center of the universe.”
But his insistence on contradicting traditional cosmology led to his arrest and trial by the Roman Catholic Church. He was forced to recant his views and imprisoned for life. The Vatican did not formally admit that Galileo was correct until 1992. Now Vatican authorities are planning a statue in his honor.
During his life, Galileo is known to have built at least 100 telescopes, mostly as ornate presentation gifts for his patrons — the powerful Medici family of Florence. Only one is known to survive with its optics intact — the humble device now on show at the Franklin Institute.
“We assume it was personally used by Galileo,” says Paolo Galluzzi, director of the science museum in Florence, which loaned the telescope for the exhibit. “Only this one was found among his property at his death. We believe that this is one of the major tools of his work.”
. . .
“Science is fundamentally about establishing truth for yourself,” says Dr. Pompea in Arizona. “People can make observations, take data and establish for themselves the nature of the universe. They don’t have to take it from someone else or read it in a book.”
Like Galileo, “they can see it.”

For the full story, see:
ROBERT LEE HOTZ. “Galileo’s Discoveries, 400 Years Later, Still Open Eyes
Astronomer’s Telescope, on View Outside Italy for the First Time, Helped Expand Perceptions of the Universe.” The Wall Street Journal (Fri., APRIL 10, 2009): A9.

(Note: ellipsis added.)

GalileoGalilei2009-08-12.gif

“Galileo Galilei.” Source of image and caption: online version of the WSJ article quoted and cited above.

“Established Experts Flee in Horror to All Available Caves and Cages”

(p. 96) While science and enterprise open vast new panoramas of opportunity, our established experts flee in horror to all available caves and cages, like so many primitives, terrified by freedom and change.

Source:
Gilder, George. Recapturing the Spirit of Enterprise: Updated for the 1990s. updated ed. New York: ICS Press, 1992.

The Conflict Between Science and Faith

Professor Krauss is a physicist at Arizona State University.

(p. A15) My practice as a scientist is atheistic. That is to say, when I set up an experiment I assume that no god, angel or devil is going to interfere with its course; and this assumption has been justified by such success as I have achieved in my professional career. I should therefore be intellectually dishonest if I were not also atheistic in the affairs of the world.

— J.B.S. Haldane

J.B.S. Haldane, an evolutionary biologist and a founder of population genetics, understood that science is by necessity an atheistic discipline. As Haldane so aptly described it, one cannot proceed with the process of scientific discovery if one assumes a “god, angel, or devil” will interfere with one’s experiments. God is, of necessity, irrelevant in science.
Faced with the remarkable success of science to explain the workings of the physical world, many, indeed probably most, scientists understandably react as Haldane did. Namely, they extrapolate the atheism of science to a more general atheism.
While such a leap may not be unimpeachable it is certainly rational, as Mr. McGinn pointed out at the World Science Festival. Though the scientific process may be compatible with the vague idea of some relaxed deity who merely established the universe and let it proceed from there, it is in fact rationally incompatible with the detailed tenets of most of the world’s organized religions. As Sam Harris recently wrote in a letter responding to the Nature editorial that called him an “atheist absolutist,” a “reconciliation between science and Christianity would mean squaring physics, chemistry, biology, and a basic understanding of probabilistic reasoning with a raft of patently ridiculous, Iron Age convictions.”

For the full commentary, see:

LAWRENCE M. KRAUSS. “OPINION: God and Science Don’t Mix; A scientist can be a believer. But professionally, at least, he can’t act like one.” The Wall Street Journal (Fri., JUNE 26, 2009): A15.

(Note: italics in original.)

Individual Independent “Biohackers” Hope to Advance Science

ClosetLaboratory2009-06-20.jpg

“Katherine’s Aull’s closet laboratory in her apartment.” Source of photo and caption: online version of the WSJ article quoted and cited below.

The individual independent scientist used to play an important role in the advance of science, but over time mainly disappeared as the academic scientist, supported by large institutions, became dominant. The dominance of funding from incumbent institutions may constrain major innovations, and so I have speculated that it might be beneficial to find ways for it again to be possible for independent individual scholars to play important roles in science.
Astronomy is one area in which this still happens. The article quoted below points to another domain in which individual scholars might be able to make contributions.

(p. A1) In Massachusetts, a young woman makes genetically modified E. coli in a closet she converted into a home lab. A part-time DJ in Berkeley, Calif., works in his attic to cultivate viruses extracted from sewage. In Seattle, a grad-school dropout wants to breed algae in a personal biology lab.

These hobbyists represent a growing strain of geekdom known as biohacking, in which do-it-yourselfers tinker with the building blocks of life in the comfort of their own homes. Some of them buy DNA online, then fiddle with it in hopes of curing diseases or finding new biofuels.
. . .
Ms. Aull, 23 years old, is designing a customized E. coli in the closet of her Cambridge, Mass., apartment, hoping to help with cancer research.
She’s got a DNA “thermocycler” bought on eBay for $59, and an incubator made by combining a styrofoam box with a heating device meant for an iguana cage. A few months ago, she talked about her hobby on DIY Bio, a Web site frequented by biohackers, and her work was noted in New Scientist magazine.
. . .
(p. A14) Phil Holtzman, a college student and part-time DJ at dance parties in Berkeley, Calif., is growing viruses in his attic that he thinks could be useful in medicine someday. Using pipettes and other equipment borrowed from his community college, he extracts viruses called bacteriophage from sewage and grows them in petri dishes. Mr. Holtzman’s goal: Breed them to survive the high temperatures of the human body, where he thinks they might be useful in killing bad bacteria.
He collects partly treated sewage water from a network of underground tunnels in the Berkeley area, jumping a chain-link fence to get to the source. But Mr. Holtzman says his roommates are “really uncomfortable” with him working with sewage water, so he’s trying to find another source of bacteriophage.

For the full story, see:
JEANNE WHALEN. “In Attics and Closets, ‘Biohackers’ Discover Their Inner Frankenstein; Using Mail-Order DNA and Iguana Heaters, Hobbyists Brew New Life Forms; Is It Risky?” Wall Street Journal (Tues., May 12, 2009): A1 & A14.
(Note: ellipses added.)

Our “Patently Absurd” Patent System

(p. A15) The Founders might have used quill pens, but they would roll their eyes at how, in this supposedly technology-minded era, we’re undermining their intention to encourage innovation. The U.S. is stumbling in the transition from their Industrial Age to our Information Age, despite the charge in the Constitution that Congress “promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries.”
. . .

Both sides may be right. New empirical research by Boston University law professors James Bessen and Michael Meurer, reported in their book, “Patent Failure,” found that the value of pharmaceutical patents outweighed the costs of pharmaceutical-patent litigation. But for all other industries combined, they estimate that since the mid-1990s, the cost of U.S. patent litigation to alleged infringers ($12 billion in legal and business costs in 1999) is greater than the global profits that companies earn from patents (less than $4 billion in 1999). Since the 1980s, patent litigation has tripled and the probability that a particular patent is litigated within four years has more than doubled. Small inventors feel the brunt of the uncertainty costs, since bigger companies only pay for rights they think the system will protect.
These are shocking findings, but they point to the solution. New drugs require great specificity to earn a patent, whereas patents are often granted to broad, thus vague, innovations in software, communications and other technologies. Ironically, the aggregate value of these technology patents is then wiped out through litigation costs.
Our patent system for most innovations has become patently absurd. It’s a disincentive at a time when we expect software and other technology companies to be the growth engine of the economy. Imagine how much more productive our information-driven economy would be if the patent system lived up to the intention of the Founders, by encouraging progress instead of suppressing it.

For the full commentary, see:
L. GORDON CROVITZ. “OPINION: INFORMATION AGE; Patent Gridlock Suppresses Innovation.” Wall Street Journal (Mon., JULY 14, 2008): A15.
(Note: ellipsis added.)

If the Medici Had Not Intervened, Galileo “Would Have Been Killed”

(p. D7) The Franklin Institute and its aspiring blockbuster, “Galileo, the Medici & the Age of Astronomy,” are something of an odd couple — a circumstance explained, like so much else, by history.
. . .

Meanwhile, the exhibition leaves provocative questions — about the nexus of church and state, as well as science and faith — unanswered. If Galileo was still a court favorite, and science was so revered in Florence, why weren’t the powerful dukes able to prevent his 1633 trial, heresy conviction, and sentence of house arrest?
Galileo’s patrons did, in fact, intervene on his behalf, Filippo Camerota, vice director of the Institute and Museum for the History of Science and one of the exhibition curators, said in an interview. “If the Medici were not there,” Mr. Camerota said, “he would have been killed.” Good to know.

For the full commentary, see:
JULIA M. KLEIN. “Exhibition; What Galileo Saw.” Wall Street Journal (Tues., APRIL 28, 2009): D7.
(Note: ellipsis added.)

RIP Marjorie Grene, Who Helped Polanyi with Personal Knowledge

GreneMarjorie2009-06-10.jpg

“Marjorie Grene in 2003.” Source of photo and caption: online version of the NYT obituary quoted and cited below.

The NYT reported, in the obituary quoted below, that philosopher Marjorie Grene died on March 16, 2009, at the age of 93.
Although I studied philosophy at the University of Chicago, my time there did not overlap with Marjorie Grene’s and I don’t believe that I ever met her, or ever even heard her speak (though I did occasionally walk past her former husband David Grene, on my way to talk to Stephen Toulmin).
I am increasingly appreciating Michael Polanyi’s book Personal Knowledge in which he introduced his view of what he called “tacit knowledge.” In particular, I am coming to believe that tacit knowledge is very important in understanding the role and importance of the entrepreneur.
So if Marjorie Grene was crucial to Personal Knowledge, as is indicated in the obituary quoted below, then she is deserving of serious consideration, and high regard.

(p. 23) In Chicago, she had met Michael Polanyi, a distinguished physical chemist turned philosopher; she ended up helping him research and develop his important book “Personal Knowledge” (1958). The book proposed a far more nuanced, personal idea of knowledge, and directly addressed approaches to science.

“There is hardly a page that has not benefited from her criticism,” Dr. Polanyi wrote in his acknowledgments. “She has a share in anything I may have achieved here.”
. . .
Her sense of humor sparkled when she was asked about being the first woman to have an edition of the Library of Living Philosophers devoted to her — Volume 29 in 2002. Previous honorees included Bertrand Russell and Einstein. “I thought they must be looking desperately for a woman,” Dr. Grene said.

For the full obituary, see:
DOUGLAS MARTIN. “Marjorie Grene, a Leading Philosopher of Biology, Is Dead at 98.” The New York Times, First Section (Sun., March 29, 2009): 23.
(Note: ellipsis added.)

The reference for the Polanyi book, is:
Polanyi, Michael. Personal Knowledge: Towards a Post-Critical Philosophy. Chicago: University Of Chicago Press, 1958.

To Cure Fatal Diseases We Need More Financial Incentives and Fewer F.D.A. Restrictions

ThompsonJoshuaAndSons.jpg

“JOSHUA THOMPSON with his sons, Wyatt and Jordan, after his diagnosis, top, and before, with his wife, Joy, and Wyatt.” Source of the photos and caption: online version of the NYT article quoted and cited below.

(p. 1) VIRGINIA BEACH — As Lou Gehrig’s disease sapped Joshua Thompson of his ability to move and speak last fall, he consistently summoned one question from within the prison of his own body. “Iplex,” he asked, in a whisper that pierced his mother’s heart. “When?”

Iplex had never been tested in people with amyotrophic lateral sclerosis, the formal name for the fatal disease that had struck Joshua, 34, in late 2006. Developed for a different condition and banished from the market by a patent dispute, it was not for sale to the public anywhere in the world.
But Kathy Thompson had vowed to get it for her son. On the Internet, she had found enthusiastic reviews from A.L.S. patients who had finagled a prescription for Iplex when it was available, along with speculation by leading researchers as to why it might slow the progressive paralysis that marks the disease. And for months, as she begged and bullied biotechnology companies, members of Congress, Italian doctors and federal drug regulators, she answered Joshua the same way:
“Soon,” she said. “Soon.”
At a time when terminally ill patients have more access to medical research than ever before, and perhaps a deeper conviction in its ability to cure them, many are campaigning for the chance to be treated with drugs whose safety and effectiveness is not yet known.
. . .
(p. 19) “Josh’s sadness is unbearable,” his mother wrote one night in her journal, nearly a year after her son’s diagnosis.
Unexpected encouragement came in a Mother’s Day note from her ex-husband. “You have given me some peace of mind that all potential options for Josh are being researched and acted upon,” Bruce wrote. “Thank you.”
Kathy’s boyfriend accompanied her to Insmed’s headquarters in Richmond, Va., offering to raise several million dollars to underwrite a compassionate use program for Iplex in the United States with A.L.S. patients. But the couple came away with a new understanding: F.D.A. regulations, they were told, prohibit any company from profiting on compassionate use. Even if Insmed could wriggle free of restrictions in the patent agreement, there was little financial incentive for it to invest in making the drug solely for compassionate use by A.L.S. patients.
. . .
On Jan. 16, when Dr. Werwath called to tell her the application had been rejected, she stood up in disbelief.
“How could that be?” she asked, dazed.
Kathy’s friend Mrs. Reimers had received a call with the same news.
“He said they had safety concerns,” Mrs. Reimers said. “This for a drug that was approved for children!”
“Safety,” Kathy repeated. “And what, exactly, is safe about A.L.S.?”

Appealing an F.D.A. Denial
Before the F.D.A.’s decision, Kathy had spared little thought for any broader meaning of her quest for Joshua. But when she met with Richard A. Samp, a lawyer with the Washington Legal Foundation a week later, her outrage went beyond her son, and beyond Iplex.
“The F.D.A. is supposed to protect American citizens,” Kathy fumed over an iced tea in Williamsburg, Va. “How does denying dying patients access to this drug serve the common good?”
Mr. Samp had handled a lawsuit by a patient advocacy group, the Abigail Alliance, that had sought to establish a constitutional right for terminally ill patients to use experimental drugs. In the case, which the group had lost on appeal in 2007, the F.D.A. claimed that it granted “nearly all” requests for compassionate use.
They would first make an administrative appeal, Mr. Samp told Kathy, asserting that the F.D.A. had violated its own guidelines. If that failed, they could pursue litigation that might allow them to raise the constitutional question again in a federal court in Virginia.
. . .
Kathy was pouring milk for her cereal on the morning of March 10 when Dr. Werwath’s number flashed on her phone. The F.D.A. had just reversed itself, he said.
Before she could take a breath, Senator Mark Warner’s office called. E-mail bleeped in as the news seeped out.
In the weeks after the appeal, Kathy learned, the F.D.A. had reached out to Insmed. The agency had persuaded the company to run a clinical trial for Iplex with several dozen A.L.S. patients, and permitted it to recoup the hefty costs directly from participants. In the trial, some of the participants would get a placebo. That way, the F.D.A. wrote on its Web site, the next wave of A.L.S. patients would learn whether the drug was in fact beneficial or harmful.
But for now, the agency had ruled, Joshua and 12 other patients would be given Iplex outside of the trial, on a compassionate use basis, if they agreed to read all the data about the risks.

For the full version of a very long story, see:
AMY HARMON. “Months to Live; Fighting for a Last Chance at Life; One Family’s Tenacious Campaign for Access to an Unproven Drug.” The New York Times, First Section (Sun., May 17, 2009): 1, 18-19.
(Note: ellipses added.)

ThompsonJoshuaIplexInjection2009-06-10.jpg“IN MARCH, Joshua Thompson received his first Iplex injection, from Dr. David L. Werwath. Thereafter Joshua’s wife, Joy, left, and mother, Kathy, took over the daily duties.” Source of the photo and caption: online version of the NYT article quoted and cited above.